Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
NCT03540303
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
OTHER_GOV
Sponsor class
Conditions
Relapsed Non Hodgkin Lymphoma
Interventions
DRUG:
CAR19 T cells carrying cytoplasmic activated PD-1
Sponsor
Henan Cancer Hospital
Collaborators
[object Object]